TITLE

Fertility preservation in cancer patients

AUTHOR(S)
Asefi, F.
PUB. DATE
June 2014
SOURCE
Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p125
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
Introduction: Survival rates for childhood cancer have improved greatly during the past few decades. With increasing numbers of children cured, attention has focused on their quality of life. fertility preservation is now being recognized as an issue of great importance. Materials and Methods: In this review article, electronic searches were undertaken inPubMed, Scholar google and up to date since 2014. Results: The established means of preserving fertility include embryo cryopreservation, gonadal shielding during radiation therapy, ovarian transposition, conservative gynecologic surgery such as radical trachelectomy, donor embryos/oocytes, gestational surrogacy, and adoption. The experimental methods include oocyte cryopreservation, ovarian cryopreservation and transplantation, in vitro maturation, and ovarian suppressionin. In men the established means of preserving fertility include the use of assisted reproductive techniques (ART), cryopreserved sperm in the setting of very low numbers of stored sperm, intracytoplasmic sperm injection for men with poor sperm quality and experimental protocols, such as testicular tissue cryopreservation. Conclusion: With advances in methods for the preservation of fertility, providing information about risk of infertility and possible options of fertility preservation to all young patients with cancer, and discussing future fertility with them should be also considered as one of the important parts of consultation at the time of cancer diagnosis. Since the efficacy of ART is significantly reduced after chemotherapy, early referral for fertility preservation before gonadotoxic treatment will give these young women the best chance to conceive.
ACCESSION #
96841800

 

Related Articles

  • Fertility preservation and breast cancer: a review. de Pedro, María; Otero, Borja; Martín, Belén // Ecancermedicalscience;2015, Vol. 9 Issue 496-518, p1 

    Breast cancer is the most common malignancy in women, and its incidence increases with age, with the majority of patients diagnosed after menopause. However, in 15–25% of cases, patients are premenopausal at the time of diagnosis, and about 7% of them are below the age of 40. Therefore, a...

  • A brief history of oocyte cryopreservation: Arguments and facts. Iussig, Benedetta; Maggiulli, Roberta; Fabozzi, Gemma; Bertelle, Sara; Vaiarelli, Alberto; Cimadomo, Danilo; Ubaldi, Filippo M.; Rienzi, Laura // Acta Obstetricia et Gynecologica Scandinavica;May2019, Vol. 98 Issue 5, p550 

    The term "cryopreservation" refers to the process of cooling cells and tissues and storing them at subzero temperatures in order to stop all biological activity and preserve their viability and physiological competences for future use. Cooling to subzero temperatures is not a physiological...

  • IVF for fertility preservation in breast cancer patients-efficacy and safety issues. Shapira, M.; Raanani, H.; Meirow, D. // Journal of Assisted Reproduction & Genetics;Aug2015, Vol. 32 Issue 8, p1171 

    Background: Potential risks on future fertility have become a dominant issue in consultation and management of newly diagnosed young cancer patients. Several fertility preservation strategies are currently available. Of those, ovarian stimulation followed by IVF and embryo cryopreservation is...

  • Fertility Preservation Options After Gonadotoxic Chemotherapy. Hyman, Jordana Hadassah; Tulandi, Togas // Clinical Medicine Insights: Reproductive Health;2013, Issue 7, p61 

    Chemotherapy has the potential to deplete and destroy a woman's reproductive potential. Although many oncologists are referring women for fertility preservation before chemotherapy, in many cases there is limited time for fertility preservation. This review provides an overview of the impact of...

  • Developmental potential of human oocytes matured in vitro followed by vitrification and activation. Imesch, Patrick; Scheiner, David; Xie, Min; Fink, Daniel; Macas, Erwin; Dubey, Raghvendra; Imthurn, Bruno // Journal of Ovarian Research;2013, Vol. 6 Issue 1, p1 

    Background: Oocyte in vitro maturation (IVM) and cryopreservation at the time of routine ovarian tissue freezing may be offered to cancer patients as an additional option for fertility preservation. This study aimed to investigate the developmental capacity of oocytes isolated from unstimulated...

  • Ovarian tissue and follicle culture. Hosseini, L.; Naderi, M.; Heidari, B.; Borjian Boroujeni, S.; Sarvari, A.; Behzadi, B.; Akhondi, M.; Shirazi, A. // Iranian Journal of Reproductive Medicine;Jun2014 Supplement, Vol. 12, p88 

    Introduction: Currently, the culture of cryopreserved ovarian cortical tissue that contains large number of primordial follicles is a promising fertility preservation approach in young cancer patients. This option allows immediate initiation of cancer treatment and is the only suitable choice...

  • Evaluation of ovarian and testicular tissue cryopreservation in children undergoing gonadotoxic therapies. Babayev, Samir; Arslan, Erol; Kogan, Stanley; Moy, Fred; Oktay, Kutluk // Journal of Assisted Reproduction & Genetics;Jan2013, Vol. 30 Issue 1, p3 

    Objective: Ovarian and testicular tissue cryopreservation are the only fertility preservation options for sexually immature individuals. Because of their experimental nature, it is important to determine safety and possible bundling with other medicallyindicated procedures. Study design:...

  • Fertility Preservation: A Case Series. Kamath, Mohan S.; Londhe, Vaibhav; K., Muthukumar; George, Korula // International Journal of Infertility & Fetal Medicine;Sep-Dec2011, Vol. 2 Issue 3, p114 

    Improvement in survival rates of cancer patients has lead to a shift in focus toward fertility issues, especially in young survivors. Male fertility preservation is well established. Embryo cryopreservation remains most successful female fertility preservation option. Other female fertility...

  • Evaluation of Use in Children Undergoing Gonadotoxic Therapy.  // Fertility Weekly;7/15/2013, p11 

    The article presents a study which evaluates the safety of testicular and ovarian tissue cryopreservation among children undergoing gonadotoxic therapy. The study investigates 28 females and nine males who were referred for fertility preservation. The study reveals that both testicular and...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics